YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla

Cipla

BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 19, 16:00
946.60
7.9 (0.84%)
VOLUME 964,569
LIVE
NSE
Apr 19, 15:59
946.30
8.25 (0.88%)
VOLUME 17,805,574
News on Cipla
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Government fast tracks approvals for Remdesivir capacity expansion; firms commit to cut price

7.12 pm | 14 Apr 2021 |  Source: Moneycontrol.com

The current total installed capacity of the seven manufacturers of Remdesivir is 38.80 lakh vials per month....

Cipla doubles Remdesivir production to meet 'unprecedented' demand

2.13 pm | 13 Apr 2021 |  Source: Reuters

The company is working with authorities to restrict remdesivir supply just to hospitals and places with a high burden of severe COVID-19 cases, Cipla ...

Trade Spotlight: What should investors do with Cipla, Dr Reddy’s & Infosys?

8.07 am | 13 Apr 2021 |  Source: Moneycontrol.com

Some of the stocks in focus were Dr Reddy’s Laboratories, which gained nearly 5 percent with strong volumes, Cipla that rose more than 2 percent, an...

DCGI writes to states/UTs to step up enforcement to stop hoarding, overcharging of Remdesivir

8.37 pm | 12 Apr 2021 |  Source: Moneycontrol.com

Many family members of COVID-19 patients have brought black marketing and overcharging of antiviral drug Remdesivir to the notice of DCGI. The family ...

Cipla Q4 PAT seen up 147.8% YoY to Rs. 609 cr: Sharekhan

8.12 pm | 12 Apr 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 15 percent Y-o-Y (down 2.7 percent Q-o-Q) to Rs. 5,031.7 crore, according to Sharekhan....

Buy Cipla; target of Rs 940: Dolat Capital Market

11.48 pm | 09 Feb 2021 |  Source: Moneycontrol.com

Dolat Capital Market is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 940 in its research report dated January 31...

Buy Cipla; target of Rs 950: Sharekhan

4.07 pm | 08 Feb 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 950 in its research report dated January 29, 2021....

Accumulate Cipla; target of Rs 913: Prabhudas Lilladher

6.51 pm | 04 Feb 2021 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended accumulate rating on Cipla with a target price of Rs 913 in its research report dated February 01, 2021....

Buy Cipla; target of Rs 975: ICICI Direct

5.23 pm | 04 Feb 2021 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 975 in its research report dated January 30, 2021....

Neutral Cipla; target of Rs 900: Motilal Oswal

9.07 pm | 02 Feb 2021 |  Source: Moneycontrol.com

Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 900 in its research report dated January 30, 2021....

Buy Cipla; target of Rs 1020: HDFC Securities

2.33 pm | 02 Feb 2021 |  Source: Moneycontrol.com

HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1020 in its research report dated February 01, 2...

Cipla Consolidated December 2020 Net Sales at Rs 5,168.69 crore, up 18.25% Y-o-Y

9.44 am | 02 Feb 2021 |  Source: Moneycontrol.com

NULL...

Cipla Standalone December 2020 Net Sales at Rs 3,731.55 crore, up 27.52% Y-o-Y

9.11 am | 02 Feb 2021 |  Source: Moneycontrol.com

NULL...

Cipla — Large part of COVID opportunity has played out

12.48 pm | 31 Jan 2021 |  Source: Moneycontrol.com

In the US market, Albuterol opportunity remains a key lever for Cipla at least till the time Perrigo re-enters although in terms of market share, the ...

Cipla posts strong Q3 numbers, profit more than doubles to Rs 748.15 crore

5.07 pm | 29 Jan 2021 |  Source: Moneycontrol.com

The company's revenue for the quarter came at Rs 5,168.7 crore, up 18.2 percent from Rs 4,371 crore in the year-ago quarter....

Cipla Q3 PAT seen up 74.3% YoY to Rs. 612 cr: Yash Securities

12.59 pm | 22 Jan 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 14 percent Y-o-Y (down 1.1 percent Q-o-Q) to Rs. 4985 crore, according to Yash Securities....

Cipla Q3 PAT seen up 77.2% YoY to Rs. 351 cr: Prabhudas Lilladher

10.57 pm | 18 Jan 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 15.3 percent Y-o-Y (down 1.8 percent Q-o-Q) to Rs. 4,234.6 crore, according to Prabhudas Lilladher....

Cipla Q3 PAT seen up 73.2% YoY to Rs. 608.1 cr: ICICI Direct

8.08 pm | 18 Jan 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 15.7 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs. 5,057.6 crore, according to ICICI Direct....

Buy Cipla; target of Rs 940: HDFC Securities

1.39 pm | 14 Dec 2020 |  Source: Moneycontrol.com

HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 940 in its research report dated December 14, 20...

Buy Cipla; target of Rs 887: Prabhudas Lilladher

1.37 pm | 14 Dec 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 887 in its research report dated December 14...

1 2
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.